QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
25.45
-1.23 (-4.61%)
At close: Jul 18, 2025, 4:00 PM
25.85
+0.40 (1.57%)
After-hours: Jul 18, 2025, 7:48 PM EDT
QuidelOrtho Revenue
QuidelOrtho had revenue of $692.80M in the quarter ending March 30, 2025, a decrease of -2.56%. This brings the company's revenue in the last twelve months to $2.76B, down -3.42% year-over-year. In the year 2024, QuidelOrtho had annual revenue of $2.78B, down -7.17%.
Revenue (ttm)
$2.76B
Revenue Growth
-3.42%
P/S Ratio
0.62
Revenue / Employee
$418,894
Employees
6,600
Market Cap
1.72B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
Novartis AG | 55.19B |
AstraZeneca | 54.98B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
QDEL News
- 1 day ago - Real Labs, Actual Decisions With Actionable Six Sigma Metrics - PRNewsWire
- 4 days ago - QUIDELORTHO AND BÜHLMANN LABORATORIES AG ANNOUNCE AVAILABILITY OF FECAL CALPROTECTIN (FCAL®) TURBO AND FECAL PANCREATIC ELASTASE (FPELA®) TURBO ASSAYS ON VITROS™ SYSTEMS AS A MICROTIP™ PARTNERSHIP ASSAY (MPA) - PRNewsWire
- 11 days ago - QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs - PRNewsWire
- 6 weeks ago - QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics - PRNewsWire
- 2 months ago - QuidelOrtho to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - QuidelOrtho: Stagnant Growth Means Best To Avoid (Rating Downgrade) - Seeking Alpha
- 2 months ago - QuidelOrtho Corporation (QDEL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - QuidelOrtho Reports First Quarter 2025 Financial Results - Business Wire